← All companies

IVBX

Innovent Biologics, Inc.

IVBXF EDGAR ↗

$13.36

+0.91 +7.27%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$9.10 – $15.01

Recent SEC filings

2 most recent

Other filings

F-6EF Aug 8, 2025

F-6EF FORM F-6EF Apr 17, 2019